Cochlear hits record high ahead of results announcement
MELBOURNE: Shares in hearing-aid company Cochlear hit an all-time high of $257.76 around ... read more
Telix hopeful for product approvals today posts $33m loss
MELBOURNE: Drug developer Telix is banking on its flagship prostate cancer imaging product ... read more